Assessing Lung Disease After Stem Cell Transplant
Longitudinal Pulmonary Chronic Graft-versus-host-disease (GvHD) Assessment in Hematopoietic Stem Cell Transplantation (HSCT) Patients
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 600 (estimated)
- Sponsor
- National Taiwan University Hospital · Other
This trial is looking for patients over 18 years old who are receiving their first stem cell transplant. Participants will help researchers understand lung disease after the transplant.
You may be able to join if
- I am over 18 years old.
- I will receive my first stem cell transplant.
You may not be able to join if
- I have respiratory failure.
- I am hemodynamically unstable.
- I have a pneumothorax or bronchial fistula.
- I have had an acute coronary syndrome in the last month.
- I cannot walk longer than 20 meters.
- I have severe lower-limb joint problems.
- I cannot cooperate well.
- I need all-day oxygen support.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityProspective observational study on the clinical characteristics of pulmonary graft-versus-host disease in patients after hematopoietic stem cell transplantation.
Loading trial locations…